Postallogeneic transplantation progressive multifocal leukoencephalopathy successfully treated by nivolumab-Reference-Cited by-同舟云学术

Postallogeneic transplantation progressive multifocal leukoencephalopathy successfully treated by nivolumab

Published:2019-12-03 Issue:6 Volume:188 Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Uzunov Madalina¹,Demeret Sophie²,Nguyen‐Quoc Stéphanie¹,Morel Véronique¹,Bellanger Agnès³,Chavez Houria⁴,Gasnault Jacques⁵,Leblond Véronique¹,Roos‐Weil Damien¹^ORCID

Affiliation:

1. Sorbonne Université Service d’Hématologie Clinique Hôpital Pitié‐Salpêtrière APHP Paris France

2. Département de Neurologie Sorbonne Université Hôpital Pitié‐Salpêtrière APHP Paris France

3. Pharmacie Hôpital Pitié‐Salpêtrière APHP Paris France

4. INSERM U1184 Université Paris‐Sud Le Kremlin‐Bicêtre France

5. UF SSR des Maladies Neurovirales Médecine Interne & Immunologie Clinique Centre Hospitalier Universitaire de Bicetre IMVA INSERM Le Kremlin‐Bicêtre France

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16349

Reference8 articles.

1. Restoring function in exhausted CD8 T cells during chronic viral infection

2. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy

3. PD-1 blockade for relapsed lymphoma post–allogeneic hematopoietic cell transplant: high response rate but frequent GVHD

5. Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promise and Challenges of Checkpoint Inhibitor Therapy for Progressive Multifocal Leukoencephalopathy in HIV;Current HIV/AIDS Reports;2022-10-01

2. Innovative therapeutic concepts of progressive multifocal leukoencephalopathy;Journal of Neurology;2022-01-07

3. Advances in Treatment of Progressive Multifocal Leukoencephalopathy;Annals of Neurology;2021-09-07

4. Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: Identifying relevant outcome factors;European Journal of Neurology;2021-07-26

5. Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients;Journal of Neurology;2021-07-01